跳至主要内容
临床试验/NCT02455518
NCT02455518已完成4 期

Comparative Efficacy of 4 Oral Analgesics for the Initial Management of Acute Musculoskeletal Extremity Pain

Montefiore Medical Center1 个研究点 分布在 1 个国家目标入组 416 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
416
试验地点
1
主要终点
Between Group Difference in Change in Numerical Rating Scale (NRS) Pain Scores

研究概览

简要总结

The purpose of this study is to perform a randomized, double blind 4-arm clinical trial of the comparative efficacy of 4 oral analgesics in the initial management of acute musculoskeletal extremity pain presenting to the ED.

详细描述

To perform a randomized, double blind 4-arm clinical trial of the comparative efficacy of 4 oral analgesics in the initial management of acute musculoskeletal extremity pain presenting to the ED. The 4 groups are as follows:

  1. Oxycodone/acetaminophen (5/325)
  2. Hydrocodone/acetaminophen (5/325)
  3. Codeine/acetaminophen (30/300)
  4. Ibuprofen/acetaminophen (400/1000)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Complaint of acute pain of < 7 days duration
  • Location of pain in one or more extremities defined as distal to and including the shoulder joint in the upper extremities and distal to and including the hip joint in the lower extremities;
  • Radiologic evaluation is planned

排除标准

  • Inability to confirm reliable means of phone followup.
  • Past use of methadone
  • Chronic condition requiring frequent pain management such as sickle cell disease, fibromyalgia, or any neuropathy
  • History of an adverse reaction to any of the study medications
  • Opioids taken in the past 24 hours
  • Ibuprofen or acetaminophen taken in past 8 hours
  • Pregnancy by either urine or serum HCG testing
  • Breastfeeding per patient report
  • History of peptic ulcer disease
  • Report of any prior use of recreational narcotics
  • Medical condition that might affect metabolism of opioid analgesics, acetaminophen, or ibuprofen such as hepatitis, renal insufficiency, hypo- or hyperthyroidism, Addison's or Cushing's disease
  • Taking any medicine that might interact with one of the study medications, such as antidepressant SSRI's or Tricyclics, antipsychotics, anti-malaria medications quinidine or halofantrine, Amiodarone or Dronedarone, diphenhydramine, celecoxib, ranitidine, cimetidine, ritanovir, terbinafine, or St John's Wort.

研究组 & 干预措施

Oxycodone/acetaminophen

Active Comparator

Oxycodone/acetaminophen (5 mg/325 mg)

干预措施: Oxycodone/acetaminophen (Drug)

Hydrocodone/acetaminophen

Active Comparator

Hydrocodone/acetaminophen (5 mg/300 mg)

干预措施: Hydrocodone/acetaminophen (Drug)

Codeine/acetaminophen

Active Comparator

Codeine/acetaminophen (30 mg/300 mg)

干预措施: Codeine/acetaminophen (Drug)

Ibuprofen/acetaminophen

Active Comparator

Ibuprofen/acetaminophen (400 mg/1000 mg)

干预措施: Ibuprofen/acetaminophen (Drug)

结局指标

主要结局

Between Group Difference in Change in Numerical Rating Scale (NRS) Pain Scores

时间窗: 2 hours

Change in numerical rating scale (NRS) pre and 2 hours post receiving study medication while in the ED. The NRS is a validated 11-point numerical scale that ranges from 0 (no pain) to 10 (worst pain possible)

次要结局

  • Between Group Difference in Change in Numerical Rating Scale (NRS) Pain Scores(1 hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew Chang, MD

PI

Montefiore Medical Center

研究点 (1)

Loading locations...

相似试验